Bausch Health Files 8-K on Officer/Director Changes
Ticker: BHC · Form: 8-K · Filed: Jul 10, 2025 · CIK: 885590
Sentiment: neutral
Topics: management-change, governance, filing
Related Tickers: BHC
TL;DR
Bausch Health (BHC) filed an 8-K detailing exec/board changes and compensation.
AI Summary
Bausch Health Companies Inc. filed an 8-K on July 10, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements/exhibits.
Why It Matters
Changes in directors and officers, along with compensatory arrangements, can signal shifts in company strategy or governance that may impact investors.
Risk Assessment
Risk Level: medium — Changes in key personnel and compensation can indicate internal shifts that may affect future performance or strategy.
Key Players & Entities
- Bausch Health Companies Inc. (company) — Registrant
- July 10, 2025 (date) — Date of Report
- Valeant Pharmaceuticals International, Inc. (company) — Former Company Name
- BIOVAIL Corp (company) — Former Company Name
FAQ
What specific officer positions were affected by the changes reported in the 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers', but does not specify the exact positions in the provided text.
Were there any new directors elected to the board?
Yes, the filing explicitly mentions 'Election of Directors' as a reported item.
What is the significance of the 'Regulation FD Disclosure' item?
Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed to all investors simultaneously, preventing selective disclosure.
What is the former name of Bausch Health Companies Inc. mentioned in the filing?
The filing lists 'Valeant Pharmaceuticals International, Inc.' and 'BIOVAIL Corp' as former company names.
What is the primary business of Bausch Health Companies Inc. according to the SIC code?
The Standard Industrial Classification (SIC) code provided is 2834, which corresponds to 'PHARMACEUTICAL PREPARATIONS'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding Bausch Health Companies Inc. (BHC).